期刊
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
卷 35, 期 6, 页码 711-714出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/JCP.0000000000000412
关键词
antipsychotic-related akathisia; low-dose mirtazapine; serotonin 2A receptor antagonism
Akathisia remains a prevalent, clinically significant, and therapeutically challenging adverse event associated with antipsychotic treatment. Compelling evidence supports therapeutic efficacy and clinical utility of agents with marked serotonin 2A receptor antagonism, primarily low-dose mirtazapine, as an effective and well-tolerated antiakathisia treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据